In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

As per Vantage Market Research, the Global Pharmaceutical Sterility Testing Market has been significantly growing over the years due to factors such as increasing R&D activities in the pharmaceutical ...

ONCOLYTIC viral therapy may offer new hope for patients with nonmelanoma skin cancers and cutaneous lymphomas, according to a new systematic review of published and ongoing research. With rising ...

In an intriguing development at MIT, engineers have managed to imbue bacteria with the ability to emit signals detectable from a significant distance. Through cutting-edge manipulation ...

A Vermont firm has recalled more than 1,700 pounds of butter because it may be contaminated with coliform, a type of bacteria found in fecal matter. Agri-Mark Inc., of Waitsfield, Vermont ...

(Cabot Creamery via AP) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] A Vermont firm has recalled more than 1,700 pounds of butter because it may be contaminated with coliform, ...

Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized ...

Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

Biotech executives and venture capital investors are banding together to press Congress to act on Food and Drug Administration layoffs they say are already impacting drug development. In a letter to ...